This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Recognizing the growing number of generic drug studies being conducted in India and the proliferation of contract research organizations in that country, Thermo Fisher Scientific this week announced that it is collaborating with Megaware to provide an automated software solution for bioequivalence studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.